Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride.

Frank GK, Bailer UF, Henry SE, Drevets W, Meltzer CC, Price JC, Mathis CA, Wagner A, Hoge J, Ziolko S, Barbarich-Marsteller N, Weissfeld L, Kaye WH.

Biol Psychiatry. 2005 Dec 1;58(11):908-12. Epub 2005 Jun 29.

PMID:
15992780
2.

Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.

Bailer UF, Frank GK, Price JC, Meltzer CC, Becker C, Mathis CA, Wagner A, Barbarich-Marsteller NC, Bloss CS, Putnam K, Schork NJ, Gamst A, Kaye WH.

Psychiatry Res. 2013 Feb 28;211(2):160-8. doi: 10.1016/j.pscychresns.2012.06.010. Epub 2012 Nov 13.

3.

The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.

Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M.

Addiction. 2013 May;108(5):953-63. doi: 10.1111/add.12066. Epub 2013 Jan 3.

PMID:
23167711
4.

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.

Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E, Reeder S, Rabiner E, Laruelle M.

Synapse. 2006 Dec 1;60(7):485-95.

PMID:
16952157
5.

The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.

Graff-Guerrero A, Mamo D, Shammi CM, Mizrahi R, Marcon H, Barsoum P, Rusjan P, Houle S, Wilson AA, Kapur S.

Arch Gen Psychiatry. 2009 Jun;66(6):606-15. doi: 10.1001/archgenpsychiatry.2009.43.

PMID:
19487625
6.

Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.

Volkow ND, Wang GJ, Logan J, Alexoff D, Fowler JS, Thanos PK, Wong C, Casado V, Ferre S, Tomasi D.

Transl Psychiatry. 2015 Apr 14;5:e549. doi: 10.1038/tp.2015.46.

7.

Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain.

Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Wong C, Ma J, Pradhan K, Tomasi D, Thanos PK, Ferré S, Jayne M.

J Neurosci. 2008 Aug 20;28(34):8454-61. doi: 10.1523/JNEUROSCI.1443-08.2008.

8.

Dopamine release in human ventral striatum and expectation of reward.

de la Fuente-Fernández R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ.

Behav Brain Res. 2002 Nov 15;136(2):359-63.

PMID:
12429397
9.

Relationship between impulsivity, prefrontal anticipatory activation, and striatal dopamine release during rewarded task performance.

Weiland BJ, Heitzeg MM, Zald D, Cummiford C, Love T, Zucker RA, Zubieta JK.

Psychiatry Res. 2014 Sep 30;223(3):244-52. doi: 10.1016/j.pscychresns.2014.05.015. Epub 2014 Jun 5.

10.

Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.

Abi-Jaoude E, Segura B, Obeso I, Cho SS, Houle S, Lang AE, Rusjan P, Sandor P, Strafella AP.

Hum Brain Mapp. 2015 Jul;36(7):2592-601. doi: 10.1002/hbm.22793. Epub 2015 Mar 18.

PMID:
25788222
11.

Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.

Hirvonen J, Karlsson H, Kajander J, Markkula J, Rasi-Hakala H, Någren K, Salminen JK, Hietala J.

Psychopharmacology (Berl). 2008 May;197(4):581-90. doi: 10.1007/s00213-008-1088-9. Epub 2008 Feb 5.

PMID:
18251011
12.

Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.

Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.

J Neurochem. 2006 May;97(4):1089-103. Epub 2006 Apr 5.

13.

In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study.

Oboshi Y, Ouchi Y, Yagi S, Kono S, Nakai N, Yoshikawa E, Futatsubashi M, Terada T, Kim K, Harada K.

J Cereb Blood Flow Metab. 2012 Apr;32(4):654-62. doi: 10.1038/jcbfm.2011.201. Epub 2012 Jan 11.

14.
15.

Striatal dopamine type 2 receptor availability in anorexia nervosa.

Broft A, Slifstein M, Osborne J, Kothari P, Morim S, Shingleton R, Kenney L, Vallabhajosula S, Attia E, Martinez D, Timothy Walsh B.

Psychiatry Res. 2015 Sep 30;233(3):380-7. doi: 10.1016/j.pscychresns.2015.06.013. Epub 2015 Jul 26.

PMID:
26272038
16.

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M.

J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57.

17.

In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.

Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M.

Synapse. 2004 Jun 1;52(3):188-208.

PMID:
15065219
18.

Dopamine release in nucleus accumbens during rewarded task switching measured by [¹¹C]raclopride.

Jonasson LS, Axelsson J, Riklund K, Braver TS, Ögren M, Bäckman L, Nyberg L.

Neuroimage. 2014 Oct 1;99:357-64. doi: 10.1016/j.neuroimage.2014.05.047. Epub 2014 May 23.

19.

NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.

Kegeles LS, Martinez D, Kochan LD, Hwang DR, Huang Y, Mawlawi O, Suckow RF, Van Heertum RL, Laruelle M.

Synapse. 2002 Jan;43(1):19-29.

PMID:
11746730
20.

Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index.

Caravaggio F, Raitsin S, Gerretsen P, Nakajima S, Wilson A, Graff-Guerrero A.

Biol Psychiatry. 2015 Jan 15;77(2):196-202. doi: 10.1016/j.biopsych.2013.02.017. Epub 2013 Mar 27. Erratum in: Biol Psychiatry. 2015 Mar 15;77(6):597.

Items per page

Supplemental Content

Write to the Help Desk